NT ANOMALY SCAN normal now IUD at 30 weeks how to send fetid for chromosomal analysis and what tests to be done

Reading Document
Medical Text Search

intrauterine fetal death stillbirth chromosomal analysis karyotyping fetal tissue

Medical Text Search

stillbirth investigation workup causes tests maternal fetal

GradeResponse
GradeResponse
Here is a comprehensive clinical guide for managing IUD (intrauterine death) at 30 weeks with a previously normal NT and anomaly scan, focusing on how to send the fetus for chromosomal analysis and the full investigative workup.

IUD at 30 Weeks — Chromosomal Analysis & Complete Workup

Context

A normal NT scan and normal anomaly scan do NOT exclude chromosomal abnormalities — they screen primarily for structural defects and common aneuploidies. Chromosomal causes (including submicroscopic deletions/duplications) still account for ~6–13% of stillbirths. A systematic workup is essential for determining cause and counselling for future pregnancies.

1. How to Send the Fetus for Chromosomal Analysis

A. Best Sample: Placental / Fetal Tissue

After delivery (or at the time of delivery), collect tissue under sterile conditions:
Sample TypeHow to CollectContainer
Placental tissue (preferred)1–2 cm² from the fetal side of placenta (not maternal side), away from infarctsSterile normal saline (NOT formalin) in a sterile container
Umbilical cord segment~2–3 cm segmentSterile saline
Fetal skin biopsyFrom inner thigh or axilla (less exposed) — if fetus already maceratedSterile saline or cytogenetics transport medium
Amniotic fluidIf still in utero (pre-delivery) — amniocentesisStandard cytogenetics container
Cord bloodIf fresh and not maceratedEDTA tube (for rapid karyotype)
Critical: Send to cytogenetics lab within 24–48 hours at room temperature (NOT refrigerated, NOT frozen). Refrigeration kills dividing cells needed for culture.

B. Tests to Request on the Sample

TestWhat it DetectsNotes
Conventional Karyotype (G-banding)Numerical anomalies (trisomies, monosomies) + large structural rearrangementsTakes 2–4 weeks; needs viable cells
Chromosomal Microarray (CMA) / Array CGHSubmicroscopic deletions & duplications (CNVs) not visible on karyotypePreferred over karyotype alone — works even on macerated/non-viable tissue (DNA-based)
FISH (Fluorescence In Situ Hybridization)Rapid detection of trisomies 13, 18, 21, X, YResult in 24–48 hrs; useful when maceration is present
Whole Exome Sequencing (WES)Monogenic disorders, if structural anomalies suspectedSecond-line if CMA normal
If macerated fetus: Karyotype culture will likely fail. CMA and FISH (on fetal tissue/DNA) are the tests of choice as they do not require live cells.

C. Labelling & Requisition Form

  • Mark clearly: "Stillbirth/IUD tissue — chromosomal analysis requested"
  • Include: gestational age, clinical history, previous scan reports, reason for referral
  • Send simultaneously to pathology (for fetal autopsy) and cytogenetics

2. Complete Investigative Workup After IUD

A. Fetal Investigations

InvestigationPurpose
Chromosomal analysis (as above)Genetic cause
Fetal autopsyStructural/pathological cause; done by perinatal pathologist
Placental histopathologyPlacental abruption, infarction, villitis, TTTS changes, hydrops
Umbilical cord examinationCord accidents (true knot, velamentous insertion, cord prolapse)
MRI fetal brain (if autopsy declined)Alternative to autopsy
Fetal swab / cultureRule out infection (Group B Strep, Listeria, CMV)
Fetal blood (if available)Cord blood gas, FBC

B. Maternal Investigations

Thrombophilia & Coagulopathy Screen

  • Antiphospholipid antibody syndrome (APS) — most important in stillbirth:
    • Lupus anticoagulant
    • Anticardiolipin antibodies (IgG & IgM)
    • Anti-β2 glycoprotein I antibodies
  • Factor V Leiden mutation
  • Prothrombin gene mutation (G20210A)
  • Protein C, Protein S, Antithrombin III

Infections

  • TORCH screen: Toxoplasma, Rubella IgG/IgM, CMV, HSV
  • Parvovirus B19 IgG/IgM
  • Syphilis (VDRL/RPR + TPHA)
  • Malaria (if endemic area)
  • Listeria cultures

Feto-Maternal Hemorrhage

  • Kleihauer-Betke test (or flow cytometry) — rule out massive feto-maternal hemorrhage

Diabetes & Metabolic

  • HbA1c (undiagnosed/poorly controlled diabetes is a major cause at 30 weeks)
  • Random/fasting blood glucose
  • Thyroid function tests (TSH, fT4)

Pre-eclampsia / Hypertension Related

  • CBC with platelets
  • Urine protein/creatinine ratio
  • LFTs, RFTs
  • Serum uric acid
  • LDH

Autoimmune

  • ANA, Anti-dsDNA (if APS suspected or autoimmune history)
  • Anti-Ro/La antibodies (fetal heart block association)

Others

  • Urine drug screen (cocaine, methamphetamine — vasospasm)
  • Bile acids (obstetric cholestasis — especially in 3rd trimester)
  • Indirect Coombs test (alloimmunisation / Rh disease)
  • Blood group and antibody screen

C. Summary Table: Priority Tests

PriorityTestTiming
ImmediateFetal tissue for CMA/FISHAt delivery — sterile, saline, room temp
ImmediatePlacenta for histopathologyAt delivery — fresh, separate pot, formalin
ImmediateMaternal blood: APS screen, Kleihauer-Betke, HbA1c, CBCAt delivery
ImmediateFetal autopsy consentBefore delivery/soon after
Within 24hTORCH, parvovirus, syphilis serologyMaternal blood
Within 24hThrombophilia screenMaternal blood
Within 24hTFTs, LFTs, bile acidsMaternal blood
6 weeks laterRepeat APS antibodies(Must be positive on 2 occasions ≥12 weeks apart to diagnose APS)

3. Key Points for This Case

  • Normal NT + normal anomaly scan does NOT exclude chromosomal microarray-detectable CNVs or late-onset causes (APS, diabetes, cholestasis, cord accident)
  • CMA is preferred over conventional karyotype in stillbirth — it works on degraded DNA and has higher diagnostic yield
  • If the fetus is macerated, prioritize CMA and FISH over culture-based karyotype
  • Autopsy + placental histopathology together identify a cause in ~40–50% of stillbirths
  • Even after full workup, ~25–35% of stillbirths remain unexplained ("unexplained stillbirth")
  • Counsel parents: results take 2–6 weeks; offer bereavement support and follow-up consultation

For future pregnancy counselling: Once results are available, offer genetic counselling if a chromosomal/genetic cause is found. If workup is negative, recurrence risk counselling should still address modifiable risk factors (obesity, diabetes, APS prophylaxis with aspirin + LMWH if diagnosed).
This is a shared conversation. Sign in to Orris to start your own chat.